Advaxis, Inc. to Present at NYC MedTech Program

PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis, Inc., (OTCBB: ADXS), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that Thomas A. Moore, Chairman & CEO of Advaxis, will present at the NYC MedTech Program, a medical technology and life science forum founded by John Lieberman CPA, Managing Director of Perelson Weiner LLP. The Program will be held on Tuesday, December 4, 2012 at the offices of Kaye Scholer LLP in New York City. More information can be found at www.nycmedtech.com.